AUGX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AUGX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Augmedix's operating assets for the quarter that ended in Jun. 2024 was $25.45 Mil. Augmedix's operating liabilities for the quarter that ended in Jun. 2024 was $17.92 Mil. Augmedix's Total Assets for the quarter that ended in Mar. 2024 was $59.56 Mil. Therefore, Augmedix's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.13.
The historical data trend for Augmedix's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Augmedix Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Scaled Net Operating Assets | -3.95 | -0.17 | -0.08 | -0.05 | 0.09 |
Augmedix Quarterly Data | |||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Scaled Net Operating Assets | Get a 7-Day Free Trial | 0.10 | 0.06 | 0.07 | 0.09 | 0.13 |
For the Health Information Services subindustry, Augmedix's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Augmedix's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Augmedix's Scaled Net Operating Assets falls into.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Augmedix's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as
Scaled Net Operating Assets (SNOA) | (A: Dec. 2023 ) | ||||
= | (Operating Assets (A: Dec. 2023 ) | - | Operating Liabilities (A: Dec. 2023 )) | / | Total Assets (A: Dec. 2022 ) |
= | (20.495 | - | 17.545) | / | 33.641 |
= | 0.09 |
where
Operating Assets | (A: Dec. 2023 ) | ||
= | Total Assets | - | Cash, Cash Equivalents, Marketable Securities |
= | 66.712 | - | 46.217 |
= | 20.495 |
Operating Liabilities | (A: Dec. 2023 ) | ||||
= | Total Liabilities | - | Long-Term Debt & Capital Lease Obligation | - | Short-Term Debt & Capital Lease Obligation |
= | 43.391 | - | 19.352 | - | 6.494 |
= | 17.545 |
Augmedix's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as
Scaled Net Operating Assets (SNOA) | (Q: Jun. 2024 ) | ||||
= | (Operating Assets (Q: Jun. 2024 ) | - | Operating Liabilities (Q: Jun. 2024 )) | / | Total Assets (Q: Mar. 2024 ) |
= | (25.452 | - | 17.923) | / | 59.556 |
= | 0.13 |
where
Operating Assets | (Q: Jun. 2024 ) | ||
= | Total Assets | - | Cash, Cash Equivalents, Marketable Securities |
= | 53.672 | - | 28.22 |
= | 25.452 |
Operating Liabilities | (Q: Jun. 2024 ) | ||||
= | Total Liabilities | - | Long-Term Debt & Capital Lease Obligation | - | Short-Term Debt & Capital Lease Obligation |
= | 43.198 | - | 18.843 | - | 6.432 |
= | 17.923 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Augmedix's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Ginocchio | officer: Chief Financial Officer | C/O AUGMEDIX, INC., 111 SUTTER STREET, SUITE 1300, SAN FRANCISCO CA 94104 |
Saurav Chatterjee | officer: CHIEF TECHNOLOGY OFFICER | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
Emmanuel Krakaris | director, officer: PRESIDENT, CEO, AND SECRETARY | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
Ian Shakil | officer: CHIEF STRATEGY OFFICER | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
Sandra Breber | officer: CHIEF OPERATING OFFICER | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
Jonathan Hawkins | officer: Chief Revenue Officer | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
Redmile Group, Llc | director, 10 percent owner | ONE LETTERMAN DRIVE, BUILDING D, SUITE D3-300, SAN FRANCISCO CA 94129 |
Margie L. Traylor | director | 5130 E. CASCALOTE DR, CAVE CREEK AZ 85331 |
Redco Ii Master Fund, L.p. | director, 10 percent owner | ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129 |
Robert C. Faulkner | director | C/O REDMILE GROUP, ONE LETTERMAN DRIVE, BUILDING D, SUITE D, SAN FRANCISCO CA 94129 |
Roderick H. O'reilly | director | C/O CHANGE HEALTHCARE INC., 3055 LEBANON PIKE, SUITE 1000, NASHVILLE TN 37214 |
Mckesson Ventures, Llc | director, 10 percent owner | ONE POST STREET, SAN FRANCISCO CA 94104 |
William J Febbo | director | 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108 |
Laurie Mcgraw | director | 4720 E COTTON GIN LOOP, SUITE 220, C/O MEDAVAIL HOLDINGS, INC., PHOENIX AZ 85040 |
Jason Krikorian | director, 10 percent owner | C/O AUGMEDIX, INC., 1161 MISSION STREET, SUITE LL, SAN FRANCISCO CA 94103 |
From GuruFocus
By Marketwired • 08-12-2024
By Marketwired • 08-06-2024
By PRNewswire • 12-13-2023
By Marketwired • 07-30-2024
By PRNewswire • 07-24-2024
By Marketwired • 04-30-2024
By PRNewswire • 09-07-2024
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 04-10-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.